Approximately 23–66% of p16 methylation frequencies were recorded in primary undifferentiated NPC, followed by 46.4% in nasopharyngeal brushings and 42% in plasma [31,32,33,34,35]. Here, CDKN2A is linked to nasopharyngeal carcinoma.